Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Lippman

Showing results (21-30 of 340) with videos related to

Pageof 34
Sort By:
Lancet (London, England)|November 1, 2011
Aspirin and colorectal cancer prevention in Lynch syndromeAndrew T Chan, Scott M Lippman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Cancer prevention by delay. Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002Scott M Lippman, Waun Ki Hong
Cancer Cell|October 19, 2004
The convergence of cancer prevention and therapy in early-phase clinical drug developmentJames L Abbruzzese, Scott M Lippman
The New England Journal of Medicine|January 5, 2007
Molecular signatures of lung cancer--toward personalized therapyRoy S Herbst, Scott M Lippman
Progress in Experimental Tumor Research|June 11, 2003
COX-2 inhibitors and other NSAIDs in bladder and prostate cancerAnita L Sabichi, Scott M Lippman
Seminars in Oncology|June 5, 2004
COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancerAnita L Sabichi, Scott M Lippman
Journal of the National Cancer Institute|March 12, 2009
Nutritional prevention of cancer: new directions for an increasingly complex challengeAlan R Kristal, Scott M Lippman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2009
Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trialElizabeth A Platz, Scott M Lippman
Journal of Hematology & Oncology|December 3, 2021
Therapeutic implications of cancer gene amplifications without mRNA overexpression: silence may not be goldenAmélie Boichard, Scott M Lippman, Razelle Kurzrock
The Lancet. Oncology|August 1, 2017
Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidenceJacqueline Kerr, Cheryl Anderson, Scott M Lippman
Pageof 34

Showing results (21-30 of 340) with videos related to

Sort By:
Pageof 34
Lancet (London, England)|November 1, 2011
Aspirin and colorectal cancer prevention in Lynch syndromeAndrew T Chan, Scott M Lippman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Cancer prevention by delay. Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002Scott M Lippman, Waun Ki Hong
Cancer Cell|October 19, 2004
The convergence of cancer prevention and therapy in early-phase clinical drug developmentJames L Abbruzzese, Scott M Lippman
The New England Journal of Medicine|January 5, 2007
Molecular signatures of lung cancer--toward personalized therapyRoy S Herbst, Scott M Lippman
Progress in Experimental Tumor Research|June 11, 2003
COX-2 inhibitors and other NSAIDs in bladder and prostate cancerAnita L Sabichi, Scott M Lippman
Seminars in Oncology|June 5, 2004
COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancerAnita L Sabichi, Scott M Lippman
Journal of the National Cancer Institute|March 12, 2009
Nutritional prevention of cancer: new directions for an increasingly complex challengeAlan R Kristal, Scott M Lippman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2009
Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trialElizabeth A Platz, Scott M Lippman
Journal of Hematology & Oncology|December 3, 2021
Therapeutic implications of cancer gene amplifications without mRNA overexpression: silence may not be goldenAmélie Boichard, Scott M Lippman, Razelle Kurzrock
The Lancet. Oncology|August 1, 2017
Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidenceJacqueline Kerr, Cheryl Anderson, Scott M Lippman
Pageof 34